Artificial intelligence (AI) surgery tech startup Caresyntax has announced that it raised $180 million through a series C extension and growth debt expansion round.
The funding comprised $80 million of equity and up to $100 million of growth debt facility.
Investors in the funding round included Symbiotic Capital, MTIP AG, BIONIQ Capital, PFM Health Sciences, Pictet Alternative Advisors, surgical.ai, BlackRock Innovation Capital, Aescuvest, Optum Ventures, Cure Capital, Relyens Group, Vesalius Biocapital, Lauxera Capital, Plug & Play Growth Fund, and ProAssurance Corp.
“This financing is not just an investment in Caresyntax, but an investment in the future of surgery. My gratitude extends to our investors who contribute to and believe in the power of smart data and AI usage in the operating room,” Dennis Kogan, Co-Founder and CEO of Caresyntax, said in a statement.
The company said that the fresh funding will be used for scaling customer adoption of surgical software tools and for continued development of the firm’s AI and edge-to-cloud applications.
“We were impressed with Caresyntax’s growth across hospitals, medtechs and insurers and look forward to working together to continue to scale their platform,” said Himani Bhalla, Chief Investment Officer of Symbiotic Capital.
Caresyntax serves more than 30,000 surgical professionals across over 3,000 operating rooms globally, delivering automation and actionable insights to hospitals, medical device companies and insurance groups.
The startup leverages tech and AI to collect, integrate, and analyse unique and comprehensive data, providing caregivers with real-time and long-term clinical decision support that enhances the patient journey, boosts hospital operational efficiency, and drives better patient outcomes and profitability.
Since Caresyntax’s 2021 Series C fundraise, the company has launched innovative AI products which are being utilised by care teams internationally and opened new markets relating to insurance underwriting and medtech clinical outcome analysis, the startup mentioned.